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ORIGINAL ARTICLE
Delayed effects of a single-dose whole-brain radiation therapy on glucose
metabolism and myelin density: a longitudinal PET study
Andrea Parentea , Elisa Scandiuzzi Maciela , Rudi A. J. O. Dierckxa , Johannes A. Langendijkb ,
Erik F. J. de Vriesa , and Janine Doorduina
aDepartment of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of
Groningen, Groningen, The Netherlands; bDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen,
Groningen, The Netherlands
ABSTRACT
Purpose: Radiotherapy is an important treatment option for brain tumors, but the unavoidable
irradiation of normal brain tissue can lead to delayed cognitive impairment. The mechanisms
involved are still not well explained and, therefore, new tools to investigate the processes leading
to the delayed symptoms of brain irradiation are warranted. In this study, positron emission tom-
ography (PET) is used to explore delayed functional changes induced by brain irradiation.
Materials and methods: Male Wistar rats were subjected to a single 25-Gy dose of whole brain
X-ray irradiation, or sham-irradiation. To investigate delayed effects of radiation on cerebral glu-
cose metabolism and myelin density, 18F-fluorodeoxyglucose (18F-FDG) PET scans were performed
at baseline and on day 64 and 94, whereas N-11C-methyl-4,40-diaminostilbene (11C-MeDAS) PET
scans were performed at baseline and on day 60 and 90 post-irradiation. In addition, the open
field test (OFT) and novel spatial recognition (NSR) test were performed at baseline and on days
59 and 89 to investigate whether whole brain irradiation induces behavioral changes.
Results: Whole-brain irradiation caused loss of bodyweight and delayed cerebral hypometabolism,
with 18F-FDG uptake in all brain regions being significantly decreased in irradiated rat on day 64
while it remained unchanged in control animals. Only amygdala and cortical brain regions of irra-
diated rats still showed reduced 18F-FDG uptake on day 94. 11C-MeDAS uptake in control animals
was significantly lower on days 60 and 90 than at the baseline, suggesting a reduction in myelin
density in young adults. In irradiated animals, 11C-MeDAS uptake was similarly reduced on day 60,
but on day 90 tracer uptake was somewhat increased and not significantly different from baseline
anymore. Behavioral tests showed a similar pattern in control and irradiated animals. In both
groups, the OFT showed significantly reduced mobility on days 59 and 89, whereas the NSR did
not reveal any significant changes in spatial memory over time. Interestingly, a positive correlation
between the NSR and 11C-MeDAS uptake was observed in irradiated rats.
Conclusions: Whole-brain irradiation causes delayed brain hypometabolism, which is not accom-
panied by white matter loss. Irradiated animals showed similar behavioral changes over time as
control animals and, therefore, cerebral hypometabolism could not be linked to behavioral abnor-
malities. However, spatial memory seems to be associated with myelin density in irradiated rats.
Abbreviations: 11C-MeDAS: N-11C-methyl-4,40-diaminostilbene; 18F-FDG: 18F- fluorodeoxyglucose;
GEE: Generalized estimating equations model; %ID/g: Percentage of injected dose per gram tissue;
NSR: Novel spatial recognition; OFT: Open field test; PET: Positron emission tomography; PI:
Preference index; SEM: Standard error of mean; VOIs: Volumes of Interest; WBRT: Whole-brain radi-
ation therapy
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Whole-brain radiation therapy (WBRT) is an important
treatment option for extensive intracranial metastases as well
as prophylactic treatment for breast and lung cancer patients
with high risk for developing brain metastases. However, the
treatment comes with a risk: brain irradiation can lead to
impairment of brain function. This has become even more
relevant with the improvement of modern treatment techni-
ques, since more patients survive long enough to show the
delayed consequences of the therapy (Roman and Sperduto
1995; Chang et al. 2009; Greene-Schloesser et al. 2012).
Moreover, with emerging radiation techniques like pencil
beam scanning proton therapy, it becomes possible to sig-
nificantly reduce brain dose to normal tissue in primary
brain tumors treated with local irradiation.
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Radiation-induced brain injury is characterized by mem-
ory, attention and executive function loss (Balentova and
Adamkov 2015). Based on the time of appearance, symp-
toms can be divided in acute (1st month), early-delayed (till
4th–6th month) and late-delayed toxicity (from 4th to 6th
month) (Tofilon and Fike 2000; Greene-Schloesser et al.
2013). The acute and early-delayed symptoms are usually
reversible, whereas the late-delayed symptoms are often irre-
versible. Late-delayed effects often include cognitive impair-
ment, which can deeply affect the patient’s quality of life
(Liu et al. 2009; Lombardi et al. 2018; Reddy et al. 2018).
The mechanisms related to delayed effects of brain irradi-
ation are still not completely elucidated. However, in vivo
MRI studies have suggested that changes in white matter are
part of this process (Fujii et al. 2006; Sabsevitz et al. 2013;
Nieman et al. 2015) and can possibly lead to necrosis
(Furuse et al. 2015). Non-invasive in vivo imaging techni-
ques to assess the processes associated with the late-delayed
effects of brain irradiation in patients could help to improve
our understanding of the mechanisms involved and facilitate
improvement of treatment planning.
Positron emission tomography (PET) is a molecular imag-
ing technique for functional assessment of biochemical and
physiological processes. In this study, we used PET to assess
the late-delayed changes in white matter after WBRT, using
11C-MeDAS as a tracer for myelin density and 18F-FDG as a
tracer for brain glucose metabolism. Demyelination is directly
related to the white matter damage after WBRT (Burns et al.
2016; Torrens et al. 2016; Li et al. 2018), whereas glucose
metabolism could be considered a surrogate marker for neuro-
degeneration. The tracer 11C-MeDAS has previously
successfully been used for PET imaging of myelin loss and
regeneration in various rodent models for multiple sclerosis
(Wu et al. 2010, 2013; de Paula Faria et al. 2014a, 2014b,
2014c; Faria et al. 2014). 11C-MeDAS uptake as measured
in-vivo with PET showed a good correlation with postmortem
Luxol Fast Blue histochemistry for myelin density. To evaluate
behavioral changes, we used the open field test (OFT) and
novel spatial recognition (NSR) test (Sun et al. 2016).
Materials and methods
Animals
Male Wistar rats (7±2weeks old, 233–308 g) were purchased
from Harlan (The Netherlands). The rats were individually
housed in a room with a constant temperature (21±2 C) and
light/dark cycle (12:12h). Since irradiated animals can develop
a series of clinical signs of illness (e.g. damage of the skull or
oral cavity, leading to disorders in eating and weight loss), a
special protocol for their care was applied to reduce discom-
fort, starting 3 days prior to the irradiation procedure and last-
ing for 4 weeks. The protocol included high energy and moist
diet, addition of sucrose to drinking water and smearing cream
on the skin in case of hair loss. The teeth of the rats were
checked weekly and cut when necessary. The special diet and
the 1% of sucrose in water were also applied to the control
group to avoid any bias. The animal’s body weight was meas-
ured daily. All of the animal experiments were performed in
accordance to the Dutch Experimental Animals Act, approved
by the Institutional Animal Care and Use Committee of the
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Figure 1. Study design. The time points indicate the number of days after (sham-)irradiation. BL: baseline; OFT: open field test; NSR: novel spatial recognition test.
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Study design
Figure 1 summarizes the overall design of the study.
Experimental animals (n¼ 8) were submitted to irradiation
(25Gy) on day 0. 18F-FDG PET scans were performed
before whole-brain irradiation (baseline) scan and on days
64 and 94 post-irradiation. 11C-MeDAS PET scans were per-
formed at baseline and on days 60 and 90 post-irradiation.
OFT and NSR test were performed at baseline and on 59
and 89 days post-irradiation. One of the irradiated animals
died between 2 and 3months after the irradiation procedure
and, therefore, did not undergo the PET scans or behavioral
tests at the 3 months’ time point.
During this longitudinal study, we realized that aging
might have an effect on the results (Chen et al. 2011;
Mengler et al. 2014). Therefore, a group of control animals
(n¼ 8) were added later to the study. Consequently animals
were not randomized. Control animals were handled simi-
larly as experimental animals, but were submitted to sham-
irradiation (X-ray apparatus remained switched-off).
Whole-brain irradiation procedure
The procedure was performed using a self-contained X-ray
irradiator for small animals (X-RAD 320, Precision X-ray –
Pxi, Austin, TX). Rats were anesthetized with an intraperito-
neal injection of ketamine (25mg/kg) and medetomidine
(0.2mg/kg). The whole rat brain was then irradiated with
25Gy of X-rays. A whole brain lead collimator with tight
margins around the brain was designed, based on MRI scans
of five animals. The collimator was constructed in such a
way that critical structures, such as the eyes, the parotid and
tear glands, were shielded during the irradiation procedure
(Supplementary Figure 1).
PET acquisition
The 18F-FDG PET scans were performed in the morning
(always between 8:00 h and 10:30 h) using a small animal
PET camera (Focus 220, Siemens Medical Solutions, Ann
Arbor, MI). In anesthetized animals, brain glucose metabol-
ism – and, thus, 18F-FDG uptake – is low. 18F-FDG
(22.5 ± 0.9 MBq) was, therefore, injected intraperitoneally in
conscious animals to allow for tracer distribution while the
brain of the animal is active, according to the standard pro-
cedure in our institution (de Paula Faria et al. 2014b; Vallez
Garcıa et al. 2016; Kopschina Feltes et al. 2019). It has previ-
ously been reported that intraperitoneal and intravenous
injection of 18F-FDG give similar brain uptake at late time
points (Schiffer et al. 2007; Wong et al. 2011). Rats were put
back in their cage for 40min. Then, rats were anesthetized
with an isoflurane and oxygen mixture (5% induction,
1.8–2% maintenance, 0.8 L/min) and positioned in the PET
camera in a supine position with their heads in the center of
the field of view. Before the start of the scan, a drop of
blood was taken from the tail vein to determine blood glu-
cose levels using a glucose meter (Johnson & Johnson). The
glucose measurement was performed in triplicate using
different strips (Deleye et al. 2014). A 30-min static emission
scan was acquired, starting 45min after tracer injection.
After the acquisition of the emission scan was complete, a
515 s transmission scan for attenuation and scatter correc-
tion was obtained using a 57Co point source.
The 11C-MeDAS PET scans were performed in the early
afternoon. Since myelin density is not dependent on brain
activity, 11C-MeDAS could be injected intravenously in
anesthetized animals. Rats were anesthetized with an isoflur-
ane and oxygen mixture (5% induction, 2% maintenance,
0.8 L/min). 11C-MeDAS (45.4 ± 4.4 MBq) was injected via
the penile vein. After injection, the rats were kept under
light anesthesia (1.5%) to enable tracer distribution, accord-
ing to the previously described procedure (de Paula Faria
et al. 2014a, 2014b). After 30min, the rats were placed in
the PET camera in a supine position with their heads in the
center of the field of view. A transmission scan was obtained
using a 57Co point source for attenuation and scatter correc-
tion. Thirty minutes after tracer injection, a 30-min static
emission scan was acquired.
During the PET scans, heart rate and O2 saturation were
monitored, body temperature was maintained using heating
pads and eye salve was applied to prevent conjunctival
dehydration.
PET reconstruction
PET scans were reconstructed iteratively (OSEM2D, 4 itera-
tions, and 16 subsets) into a single frame of 30min after
being normalized and corrected for attenuation, scatter and
decay of radioactivity. The scans were quantitatively ana-
lyzed using PMOD 3.8 software (PMOD Technologies,
Z€urich, Switzerland). For this purpose, the reconstructed
scans were automatically registered with a reference tracer
template (Vallez Garcia et al. 2015). Volumes of Interest
(VOIs) were transferred from the template to the co-regis-
tered PET images and tracer uptake in these VOIs was
measured. VOIs were selected taking the size of brain
regions and camera resolution into consideration. Therefore,
the following brain regions were selected for investigation:
whole brain, hippocampus, hypothalamus, thalamus, stri-
atum, amygdala, midbrain, brainstem, cerebellum, frontal
cortex, temporal cortex, and parietal/occipital cortex.
18F-FDG and 11C-MeDAS radioactivity concentrations
were determined for each VOI and converted into the per-
centage of injected dose per gram of tissue (%ID/g), which
is defined as
(Radioactivity concentration in tissue [Bq/cm3] 100%)/
(Injected dose [Bq]).
It was assumed that 1 cm3 of brain tissue equals 1 g. The
18F-FDG uptake was corrected for blood glucose levels
(Woo et al. 2008; Deleye et al. 2014), according to the for-
mula: %ID/gcorr ¼ [%ID/g X blood glucose (mol/L)/5.55
(mol/L)].
One irradiated animal died on day 79 and therefore PET
scans on day 90/94 could not be acquired for this animal.
Due to technical problems with the tracer injection (injec-
tion in intestines, extravasation), four 18F-FDG PET scans
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(baseline: 1 irradiated, 2 controls; day 94: 1 control) and one
11C-MeDAS PET scan (day 90: 1 control) were excluded
from the analysis.
Open field test
Animals were allowed to acclimatize in the experimental
room for at least 1 h. The test was always performed
between 8:00 and 9:00 AM. The rats were placed in an ellip-
tical arena (126 88 60 cm) and their locomotor behavior
was recorded on video for 5min. The total distance moved
was analyzed using Ethovision XT8.5 software (Noldus
Information Technology, Wageningen, The Netherlands).
The arena was cleaned with 70% ethanol after each session
to avoid bias due to other animal’s odors.
Novel spatial recognition
The test was always performed 1 h after the OFT. The rats
were placed in a square arena (40 40 44 cm). Two
objects were placed in this arena and the rats were allowed
to explore for 5min and then returned to their home cage.
After 90min, the rats were again placed in the same arena,
only this time, one of the objects was moved to a different
position (Roozendaal et al. 2010). The behavior of the rats
was then recorded on video for 5min. The time the animals
spent exploring each object was measured and the
Preference Index (PI) (Ennaceur and Delacour 1988;
Antunes and Biala 2012) was calculated by dividing the time
spent exploring the object in a new position by the total
time exploring both objects. The object that changed posi-
tions had to be explored for at least 2.5 s in both the famil-
iarization and testing phase, and the object that remained in
the same place had to be explored for at least 1 s in the test
phase. The animals that did not reach these cut off values
were excluded from the analysis. Thus, final analysis was
performed on n¼ 6 (baseline; day 59), or n¼ 5 (day 89) in
the control group and on n¼ 6 (baseline; day 89), or n¼ 5
(day 59) in the irradiated group. The arena and the objects
were cleaned with 70% ethanol after each session to avoid
bias due to other animal’s odors.
Statistical analysis
All statistical tests were performed using SPSS 23 software
(IBM Corporations, Armonk, NY). The generalized estimat-
ing equations (GEE) model can account for missing data
and longitudinal analysis and was, therefore, used for within
group comparison of tracer uptake in each brain region, the
total distance moved in the OFT, the PI in the NSR test and
the change in bodyweight. For all parameters, within-group
analysis of the longitudinal effects of whole-brain irradiation
was performed, using the GEE model. The GEE model was
also used for between-group comparison of bodyweight and
behavior, but not for between-group comparison of PET
data, due to unexpected significant baseline differences in
18F-FDG and 11C-MeDAS uptake between control and irra-
diated animals. The independent structure was the best
working correlation matrix based on the quasi-likelihood
under the independence model information criterion value.
Post-hoc Bonferroni correction was applied to correct for
multiple comparisons and the associated p values were con-
sidered significant when p< .05.
Results
Bodyweight
Bodyweight was measured daily to assess the effect of brain
irradiation in the acute and delayed phase (Figure 2).
Statistically significant (p< .001) effects were observed in the
GEE analysis for the factors ‘time’ and ‘group’. The control
group showed a gradual increase in bodyweight over time.
The 25-Gy group, however, showed a continuous weight
loss during the first 10 days (13%) compared to day 0, and
a subsequent weight gain, without reaching the bodyweight
of the control group until the end of the experiment.
Irradiation caused a significant reduction in bodyweight, as
compared to controls (p< .001) from day 5 post-irradiation
onward. Between days 37 and 45, the irradiated rats revealed
a small period of bodyweight decrease (4.2%), which could
be due to eating problems caused by overgrowth of the
upper incisors. After the upper incisors were cut, the body-
weight slowly increased until day 59. Then, there was a tran-
sient reduction in bodyweight until day 64 (6.7%),
followed by a slow increase until day 78 post-irradiation.
We observed that the animals developed mucositis in the
oral cavity about 2months after radiotherapy, which could
explain the second transient drop in bodyweight (Maria
et al. 2017).
























Change over time (p <0.001)
Change over time different between Control and 25Gy (p <0.001) 
error bars +/- SD 
* = p <0.001
Figure 2. Average bodyweight change (g) from baseline ([bodyweight at spe-
cific time point] – [bodyweight at baseline]) from (sham-)irradiation until ter-
mination (n¼ 8, one irradiated rat died on day 79). Irradiated animals do not
gain weight in the same way as control animals. Statistical analysis (GEE model)
showed a significant effect of time on bodyweight and a significant interaction
between group and time. No statistically significant differences between groups
were observed from baseline until day 5 post-irradiation. From day 5 until the
end of the study, the bodyweight of irradiated animals was significantly lower
than controls (p< .001).
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18F-FDG PET
In the control group, neither the whole brain nor any indi-
vidual brain region showed significant changes in 18F-FDG
uptake over time. In the irradiated group, there was signifi-
cant decrease in 18F-FDG uptake (%ID/gcorr) in whole brain
(24%, p< .001) and in all individual brain regions (17–27%,
p< .01 or <.001) between baseline and day 64. On day 94,
however, 18F-FDG uptake in all brain regions tended to
increase a bit again as compared to day 64 (3–9%), although
this increase was not statistically significant. Consequently,
only the whole brain (19%, p< .05), cortical areas and
amygdala (22–24%) still showed significantly lower 18F-FDG
uptake on day 94 than at baseline (Figure 3, Table 1).
11C-MeDAS PET
In the control group, 11C-MeDAS uptake in the whole brain
and all specific brain regions significantly decreased
(13–23%, p< .001) between baseline and day 60. Between
days 60 and 90, tracer uptake remained unchanged and,
therefore, 11C-MeDAS uptake at day 90 was also signifi-
cantly lower than at baseline (15–23%, p< .001). In the irra-
diated group, 11C-MeDAS uptake in the whole brain and all
specific brain regions also showed a significant decrease
(18–24%, p< .001) between baseline and day 60. However,
11C-MeDAS uptake in irradiated animals tended to increase
again between days 60 and 90. As a result, the difference in
11C-MeDAS uptake between baseline and day 90 was no
longer statistically significant (p> .05) anymore in the whole
brain or any brain region, except in the amygdala (18%, p
.04) (Figure 4, Table 2).
Open field test
The motor activity was evaluated by the total distance the
animals moved in the OFT. The results are summarized in
Figure 5(a). Within-group analyses indicated that control
and irradiated animals behaved in the same way. Both
groups showed a significant decrease (p< .001) in total
ambulatory distance between baseline and day 59 and base-
line and day 89, but no significant differences between days
* = p <0.05
**** = p <0.0001
Figure 3. Results of 18F-FDG PET imaging of whole-brain glucose metabolism
in control animals (white bars) and irradiated rats (gray bars) at several time
points after whole-brain irradiation with 25 Gy of X-rays. Tracer uptake is
expressed as %ID/g corrected for blood glucose (mean ± SEM). Control group:
n¼ 6 (baseline), n¼ 7 (day 94), or n¼ 8 (day 64). Irradiated group: n¼ 7 (base-
line; day 94), or n¼ 8 (day 64). Significant differences are relative to baseline
values in the same group, and are indicated by p< .05 and p< .0001.
Table 1. 18F-FDG uptake, expressed as %ID/gcorr (mean ± SEM), in various brain regions of irradiated and control rats.














Amygdala 1.06 ± 0.10 0.99 ± 0.04 0.99 ± 0.05 1.62 ± 0.10 1.23 ± 0.03 1.27 ± 0.12^
Brainstem 1.07 ± 0.11 1.04 ± 0.04 1.04 ± 0.06 1.58 ± 0.08 1.30 ± 0.05^ 1.37 ± 0.13
Cerebellum 0.93 ± 0.08 0.92 ± 0.04 0.92 ± 0.06 1.49 ± 0.08 1.21 ± 0.04 1.32 ± 0.12
Frontal cortex 1.05 ± 0.07 1.04 ± 0.05 1.06 ± 0.06 1.77 ± 0.10 1.27 ± 0.05 1.38 ± 0.14^
Hippocampus 1.19 ± 0.10 1.11 ± 0.05 1.13 ± 0.06 1.89 ± 0.13 1.42 ± 0.05 1.51 ± 0.16
Hypothalamus 1.01 ± 0.12 0.97 ± 0.04 0.97 ± 0.06 1.47 ± 0.09 1.21 ± 0.05^ 1.24 ± 0.14
Midbrain 1.20 ± 0.11 1.14 ± 0.05 1.15 ± 0.07 1.82 ± 0.11 1.50 ± 0.05^ 1.60 ± 0.16
Parietal occipital cortex 1.10 ± 0.08 1.04 ± 0.04 1.06 ± 0.06 1.75 ± 0.10 1.27 ± 0.04 1.36 ± 0.14^
Striatum 1.31 ± 0.11 1.21 ± 0.05 1.24 ± 0.07 2.03 ± 0.13 1.57 ± 0.06 1.61 ± 0.20
Temporal cortex 1.14 ± 0.10 1.10 ± 0.04 1.09 ± 0.06 1.73 ± 0.08 1.30 ± 0.04 1.32 ± 0.13^
Thalamus 1.27 ± 0.11 1.21 ± 0.06 1.23 ± 0.07 1.97 ± 0.12 1.56 ± 0.06 1.69 ± 0.19
Whole brain 1.07 ± 0.09 1.02 ± 0.04 1.03 ± 0.06 1.69 ± 0.10 1.29 ± 0.04 1.37 ± 0.14#
18F-FDG uptake (%ID/gcorr) in control rats and rats exposed to a single 25-Gy dose of whole-brain irradiation, at baseline and on days 64 and 94. The p values
for the within-group analyses relative to baseline are provided: p .001; ^p .01; #p .05.




Figure 4. Results of 11C-MeDAS PET imaging of whole brain myelination in con-
trol animals (white bars) and irradiated rats (gray bars) at several time points
after whole-brain irradiation with 25 Gy of X-rays. Tracer uptake is expressed as
%ID/g (mean ± SEM). Control group: n¼ 7 (day 94), or n¼ 8 (baseline; day 64).
Irradiated group: n¼ 7 (day 94), or n¼ 8 (baseline; day 64). Significant differen-
ces are relative to baseline values in the same group, and are indicated
by p< .001.
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59 and 89. The results of the OFT did not correlate with
18F-FDG or 11C-MeDAS uptake.
Novel spatial recognition
The results of the NSR test are summarized in Figure 5(b).
Within-group analyses indicated that both control and irra-
diated animals did not show any significant change in PI
over time. However, a correlation between PI and whole
brain 11C-MeDAS uptake was observed. For the combined
data from baseline, days 60 and 90, a significant correlation
between PI and 11C-MeDAS uptake was found in the irradi-
ated group (p< .002; R2 0.51), but not in the control group
(p .92; R2 0.0007) (Figure 6).
Discussion
To our knowledge, this is the first molecular imaging study
analyzing both brain metabolism and myelin density in the
delayed phase of radiation-induced brain injury. Our study
Table 2. 11C-MeDAS uptake, expressed as %ID/g (mean ± SEM), in various brain regions of control and irradiated rats.














Amygdala 0.29 ± 0.01 0.24 ± 0.01 0.23 ± 0.01 0.34 ± 0.02 0.27 ± 0.01 0.28 ± 0.02#
Brainstem 0.48 ± 0.03 0.42 ± 0.02 0.41 ± 0.02 0.56 ± 0.04 0.46 ± 0.03 0.50 ± 0.03
Cerebellum 0.37 ± 0.02 0.31 ± 0.01 0.30 ± 0.01 0.45 ± 0.03 0.36 ± 0.02 0.39 ± 0.02
Frontal cortex 0.36 ± 0.02 0.28 ± 0.02 0.29 ± 0.02 0.45 ± 0.03 0.36 ± 0.02 0.40 ± 0.02
Hippocampus 0.38 ± 0.02 0.31 ± 0.01 0.29 ± 0.01 0.46 ± 0.03 0.36 ± 0.02 0.40 ± 0.02
Hypothalamus 0.36 ± 0.02 0.29 ± 0.01 0.28 ± 0.02 0.44 ± 0.03 0.34 ± 0.02 0.36 ± 0.02
Midbrain 0.50 ± 0.03 0.39 ± 0.02 0.39 ± 0.02 0.61 ± 0.04 0.47 ± 0.04 0.53 ± 0.03
Parietal occipital cortex 0.35 ± 0.02 0.27 ± 0.01 0.27 ± 0.02 0.42 ± 0.03 0.32 ± 0.02 0.55 ± 0.02
Striatum 0.43 ± 0.02 0.36 ± 0.01 0.36 ± 0.02 0.53 ± 0.04 0.41 ± 0.03 0.47 ± 0.03
Temporal cortex 0.30 ± 0.02 0.24 ± 0.01 0.24 ± 0.01 0.36 ± 0.02 0.28 ± 0.01 0.29 ± 0.02
Thalamus 0.46 ± 0.03 0.36 ± 0.02 0.36 ± 0.02 0.56 ± 0.04 0.43 ± 0.03 0.49 ± 0.03
Whole brain 0.38 ± 0.02 0.31 ± 0.02 0.30 ± 0.02 0.46 ± 0.03 0.36 ± 0.02 0.40 ± 0.02
11C-MeDAS uptake (%ID/g) in control rats and rats exposed to a single 25-Gy dose of whole-brain irradiation at baseline and on days 60 and
90. The p values for the within-group analysis relative to baseline are provided: p .001; #p .05.
* = p <0.001
(a) (b)
Figure 5. (a) The total distance moved in the open field test, expressed in cm (mean ± SEM; n¼ 8) (n¼ 7 for irradiated group, day 89). (b) The preference index in
the novel spatial recognition test (mean ± SEM) in control animals (white bars) and irradiated rats (gray bars) at several time points after whole brain irradiation
with 25 Gy of X-rays. Control group: n¼ 6 (baseline; day 59), or n¼ 5 (day 89). Irradiated group: n¼ 6 (baseline; day 89), or n¼ 5 (day 59). Significant differences










GroupCTRL: R2 0.00007; p <0.918 
















Figure 6. Correlation between 11C-MeDAS uptake (%ID/g) in the whole brain
and the preference index from the novel spatial recognition test. The results of
control animals (white square) and irradiated rats (gray dots) at baseline and on
day 60 and 90 after (sham-)irradiation are presented.
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aimed to reveal two characteristics of delayed toxicity after
whole-brain irradiation: hypometabolism and demyelination.
18F-FDG PET scans showed that a single 25-Gy dose of
WBRT indeed induced delayed brain glucose hypometabo-
lism in rats. Yet, 11C-MeDAS PET scans did not reveal any
demyelination in the delayed phase, but rather a possible
trend toward remyelination in the irradiated group. This is
in line with a trend toward increased 18F-FDG uptake in the
inner brain areas. The OFT and NSR test did not show any
radiation-induced delayed behavioral changes. However, 25-
Gy brain irradiation caused alopecia in the irradiated area,
damage in oral cavity and mucositis that could lead to eat-
ing problems and significant weight loss (Figure 2).
Our results show that a decrease in glucose metabolism
in the whole brain and all individual brain regions started to
appear 2months after whole-brain irradiation and persisted
only in amygdala and cortical areas after 3months. Whole-
brain hypometabolism induced by WBRT has also been
described in another preclinical (Rana et al. 2013) and some
clinical studies (Andersen et al. 2003; Clavo et al. 2009;
Robbins et al. 2012; Tallet et al. 2012). The preclinical study
by Rana et al. (2013), however, focused on the acute phase
after radiation therapy. With proton magnetic resonance
spectroscopy, they observed brain hypometabolism already
2–10 days after mice were subjected to whole-body radiation
therapy. Some clinical studies (Andersen et al. 2003; Clavo
et al. 2009; Robbins et al. 2012) analyzed the late-delayed
effects of brain irradiation, varying from 9months until
years post-exposure. In line with our findings, these studies
showed a globally decreased brain glucose metabolism,
which also included the hippocampus. The hippocampus is
closely involved in cognitive impairment, which is also a
characteristic of late-delayed radiation toxicity. In our study,
glucose metabolism in hippocampus was not more affected
than other brain regions 3months after irradiation, which
might suggest damage in hippocampus was still relatively
mild and could thus explain the absence of cognitive abnor-
malities in the NSR memory test.
In our study, the control group showed lower 11C-
MeDAS uptake at days 60 and 90 than at baseline, suggest-
ing a decrease in myelin density between baseline and days
60–90. We observed a similar pattern in myelin density
changes in irradiated rats as in controls, although there
appeared to be a non-significant tendency toward an
increase in myelin density 3months after radiation therapy,
as compared to day 60. In line with our data, previous stud-
ies suggested that demyelination after 25-Gy WBRT in
rodents is a process that mainly occurs in the acute phase
(Burns et al. 2016), with myelin density recovering to nor-
mal levels after around 3–6months (Panagiotakos et al.
2007; Fu et al. 2017). This recovery is hypothesized to occur
mainly due to the capacity of oligodendrocyte progenitor
cells to migrate to the sites of myelin damage and remyeli-
nate the injured white matter tracts.
In line with this hypothesis, we noticed that whole brain
11C-MeDAS uptake and the NSR test showed a similar tem-
poral pattern in the irradiated group. Regression analysis
indeed confirmed that the 11C-MeDAS uptake and the PI
were significantly correlated in the irradiated group when all
data from baseline, days 60, and 90 were pooled. This cor-
relation suggests that changes in myelin density are associ-
ated with altered cognitive performance in spatial
recognition. This finding is in line with new research that
recognized that white matter is equally critical for cognition
and behavior as gray matter is (Filley 2005; Fields 2008;
Filley 2012; Filley and Fields 2016).
Combining all PET imaging results, our study suggests
that the reduced brain glucose metabolism 3months after
whole brain irradiation is probably not due to white matter
involvement (oligodendrocytes), since the myelin density
seems to be normal or even slightly increased to recover
damage. Therefore, our results might point toward neur-
onal cell death of gray matter. The delayed hypometabo-
lism could be due to a lower global brain activity. Studies
in neurodegenerative diseases such as Parkinson’s and
Alzheimer’s disease (Zilberter and Zilberter 2017) have
suggested that brain hypometabolism is preceding neurode-
generation and can be aggravated as a consequence of it.
We investigated brain hypometabolism only for 3months
after WBRT and, therefore, a longer follow up may be
needed to detect late neurodegeneration and the accompa-
nying demyelination.
This study has some limitations. Most importantly, the
control group was added later in time and therefore no ran-
domization could be applied. For an unknown reason, this
has led to baseline differences in the PET data between
groups. The baseline differences in PET tracer uptake
between groups were thoroughly investigated, but could not
be explained by different tracer properties (e.g. purity, molar
activity, injected mass), animal weight and age at arrival,
camera characteristics, imaging procedures or quality of
tracer injection. These baseline differences prompted us to
perform only within-group comparisons in control and irra-
diated animals separately. Despite this limitation, it was still
possible to detect effects of brain irradiation.
Another limitation is that we used behavioral tests in this
study (OFT and NSR) that were available in our animal
facility at the time of the experiment. These tests may not
be the most sensitive ones to detect the kind of cognitive
impairment that comes with WBRT17. Moreover, in the ana-
lysis of the NSR test, we had to exclude several animals due
to insufficient exploration of the objects in the first explora-
tory round. As a result, the sample size may have been
insufficient to detect significant differences and thus a larger
number of animals may be needed. Finally, the 3months of
follow-up after WBRT in this study may still have been too
short to capture the late-delayed adverse events caused by
the treatment.
In conclusion, WBRT reduced whole-brain glucose
metabolism from 2 to 3months after treatment. This whole
hypometabolism is probably not due to involvement of
white matter, since the myelin levels were shown to be nor-
mal or even slightly increased at this time point. Statistically
significant behavioral abnormalities could not be detected in
this study, although we found correlation between myelin
density and spatial memory in the irradiated group. Apart
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from that, the imaging findings could not be linked to
delayed symptoms. Further research is needed to elucidate
the pathophysiology underlying the delayed hypometabo-
lism. For this purpose, imaging studies to investigate the
integrity of gray matter using, for example, the PET tracer
11C-flumazenil may provide more insight.
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